German American Bancorp’s Abiomed Inc ABMD Stock Holding History

German American Bancorp’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,000	Closed	-$1.23M	–	121
2022 Q3	$1.23M	Buy	+5,000	New	+$1.35M	0.21%	56

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

German American Bancorp's ABMD Position: Q4 2022 in Review

German American Bancorp sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 5,000 shares — an estimated $1.23M sold.

German American Bancorp first reported a position in ABMD in Q3 2022 and held it in 1 quarter. The position peaked at $1.23M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

German American Bancorp reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
German American Bancorp sold 5,000 Abiomed Inc shares in Q4 2022, an estimated $1.23M.
German American Bancorp first reported a position in Abiomed Inc in Q3 2022 and held it in 1 quarter.
German American Bancorp's Abiomed Inc position peaked at $1.23M in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on German American Bancorp's 13F filing for Q4 2022, filed 16 Feb 2023.